speb/financial-data huggingface dataset:
EXEL income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
EXEL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 36071000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2033536000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1969852000.00
EXEL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EXEL income_statement (quarterly, 2025-06-30) — Tax Provision: 45567000.00
EXEL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
EXEL balance_sheet (quarterly, 2025-06-30) — Total Assets: 2678081000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2033536000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Debt: 179842000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2033536000.00
EXEL income_statement (quarterly, 2025-06-30) — Total Expenses: 354685000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 644545000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1497317000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 308434000.00
EXEL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 213576000.00
EXEL income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
EXEL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
EXEL balance_sheet (quarterly, 2025-06-30) — Working Capital: 844653000.00
EXEL income_statement (quarterly, 2025-09-30) — +Operating Expense: 322825000.00
EXEL income_statement (quarterly, 2025-09-30) — +Total Revenue: 597755000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 25348000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 309725000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2262928000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 578287000.00
EXEL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 268421000.00
EXEL income_statement (quarterly, 2025-09-30) — Basic EPS: 0.72
EXEL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 164433000.00
EXEL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6731000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 176463000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 268000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 376300000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 988535000.00
EXEL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -103860000.00
EXEL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 25405000.00
EXEL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 290322000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 17755000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 903000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Inventory: -4149000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Payable: 17755000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 18658000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 47649000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Receivables: -17370000.00
EXEL cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 44788000.00
EXEL cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -17370000.00
EXEL cash_flow (quarterly, 2025-09-30) — Changes In Cash: 211867000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Common Stock: 268000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2160700000.00
EXEL cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -104035000.00
EXEL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 18574000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 81209000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Current Assets: 1402257000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 373777000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Current Provisions: 58234000.00
EXEL cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7422000.00
EXEL cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7422000.00
EXEL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 278535000.00
EXEL income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.69
EXEL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — EBIT: 256356000.00
EXEL income_statement (quarterly, 2025-09-30) — EBITDA: 263778000.00
EXEL cash_flow (quarterly, 2025-09-30) — End Cash Position: 376300000.00
EXEL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -103860000.00
EXEL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 283591000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 3565000.00
EXEL income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 123661000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Goodwill: 63684000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Gross PPE: 360737000.00
EXEL income_statement (quarterly, 2025-09-30) — Gross Profit: 579181000.00
EXEL income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
EXEL income_statement (quarterly, 2025-09-30) — Interest Income: 15922000.00
EXEL income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 15922000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Inventory: 27402000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2160700000.00
EXEL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 25405000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 578287000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 578287000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 176463000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 176463000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -104035000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 193578000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 193578000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 193578000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -5249000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Interest Income: 15922000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 32136000.00
EXEL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 15922000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3377000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Net PPE: 360737000.00
EXEL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1482000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2097016000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 418582000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 418582000.00
EXEL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 283594000.00
EXEL income_statement (quarterly, 2025-09-30) — Normalized Income: 208776872.00
EXEL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 290322000.00
EXEL income_statement (quarterly, 2025-09-30) — Operating Income: 256356000.00
EXEL income_statement (quarterly, 2025-09-30) — Operating Revenue: 836508000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 268098000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 76595000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 104622000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 3565000.00
EXEL income_statement (quarterly, 2025-09-30) — Other Gand A: 103129000.00
EXEL income_statement (quarterly, 2025-09-30) — Other Income Expense: -19865000.00
EXEL cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 13649000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 112607000.00
EXEL income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -49000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Properties: 360737000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 612235000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Payables: 25348000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 106557000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 104364000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
EXEL income_statement (quarterly, 2025-09-30) — Pretax Income: 252413000.00
EXEL cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3552000.00
EXEL cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -5249000.00
EXEL cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -189370000.00
EXEL cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1482000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Receivables: 309725000.00
EXEL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 18574000.00
EXEL income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7422000.00
EXEL cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -104035000.00
EXEL income_statement (quarterly, 2025-09-30) — Research And Development: 199164000.00
EXEL income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 19816000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -106061000.00
EXEL income_statement (quarterly, 2025-09-30) — Salaries And Wages: 20532000.00
EXEL cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 221506000.00
EXEL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 123661000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Share Issued: 268098000.00
EXEL income_statement (quarterly, 2025-09-30) — Special Income Charges: -19816000.00
EXEL cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 30885000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2160700000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2097016000.00
EXEL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -4617128.00
EXEL income_statement (quarterly, 2025-09-30) — Tax Provision: 58835000.00
EXEL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
EXEL balance_sheet (quarterly, 2025-09-30) — Total Assets: 2823547000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2160700000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Debt: 176463000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2160700000.00
EXEL income_statement (quarterly, 2025-09-30) — Total Expenses: 341399000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 662847000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1421290000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 289070000.00
EXEL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 236540000.00
EXEL income_statement (quarterly, 2025-09-30) — Total Unusual Items: -19816000.00
EXEL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -19816000.00
EXEL balance_sheet (quarterly, 2025-09-30) — Working Capital: 1028480000.00
EXEL income_statement (annual, 2025-12-31) — +Operating Expense: 1343728000.00
EXEL income_statement (quarterly, 2025-12-31) — +Operating Expense: 336272000.00
EXEL income_statement (annual, 2025-12-31) — +Total Revenue: 2320126000.00
EXEL income_statement (quarterly, 2025-12-31) — +Total Revenue: 598663000.00
EXEL balance_sheet (annual, 2025-12-31) — Accounts Payable: 29623000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 29623000.00
EXEL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 286916000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 286916000.00
EXEL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -132228000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -132228000.00
EXEL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2234411000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2234411000.00
EXEL cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
EXEL cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
EXEL income_statement (annual, 2025-12-31) — Basic Average Shares: 271567000.00
EXEL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 266458000.00
EXEL income_statement (annual, 2025-12-31) — Basic EPS: 2.88
EXEL income_statement (quarterly, 2025-12-31) — Basic EPS: 0.92
EXEL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 217374000.00
EXEL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 376300000.00
EXEL cash_flow (annual, 2025-12-31) — Capital Expenditure: -39928000.00
EXEL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7157000.00
EXEL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 173038000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 173038000.00
EXEL balance_sheet (annual, 2025-12-31) — Capital Stock: 262000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 262000.00
EXEL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 482488000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 482488000.00
EXEL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1059091000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1059091000.00
EXEL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -969594000.00
EXEL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -254568000.00
EXEL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 350441000.00
EXEL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 27241000.00
EXEL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 884267000.00
EXEL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 333515000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Account Payable: -50152000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -12900000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1899000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 355000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Inventory: 12225000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Inventory: 13806000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Payable: -50152000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Payable: -12900000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -48253000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -12545000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -133771000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -97034000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Receivables: -21398000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Receivables: 22809000.00
EXEL cash_flow (annual, 2025-12-31) — Change In Working Capital: -191197000.00
EXEL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -72964000.00
EXEL cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -21398000.00
EXEL cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 22809000.00
EXEL cash_flow (annual, 2025-12-31) — Changes In Cash: 265114000.00
EXEL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 106188000.00
EXEL balance_sheet (annual, 2025-12-31) — Common Stock: 262000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Common Stock: 262000.00
EXEL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2161319000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2161319000.00
EXEL cash_flow (annual, 2025-12-31) — Common Stock Payments: -947511000.00
EXEL cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -257618000.00
EXEL balance_sheet (annual, 2025-12-31) — Construction In Progress: 3003000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 3003000.00
EXEL income_statement (annual, 2025-12-31) — Cost Of Revenue: 83697000.00
EXEL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 26481000.00
EXEL balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 88525000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 88525000.00
EXEL balance_sheet (annual, 2025-12-31) — Current Assets: 1443289000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Current Assets: 1443289000.00
EXEL balance_sheet (annual, 2025-12-31) — Current Liabilities: 405644000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 405644000.00
EXEL balance_sheet (annual, 2025-12-31) — Current Provisions: 59896000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Current Provisions: 59896000.00
EXEL cash_flow (annual, 2025-12-31) — Deferred Income Tax: 126237000.00
EXEL cash_flow (annual, 2025-12-31) — Deferred Tax: 126237000.00
EXEL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 29055000.00
EXEL cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 6946000.00
EXEL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 29055000.00
EXEL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6946000.00
EXEL income_statement (annual, 2025-12-31) — Diluted Average Shares: 281863000.00
EXEL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 276348000.00
EXEL income_statement (annual, 2025-12-31) — Diluted EPS: 2.78
EXEL income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.88
EXEL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 244528000.00
EXEL income_statement (annual, 2025-12-31) — EBIT: 892701000.00
EXEL income_statement (quarterly, 2025-12-31) — EBIT: 235910000.00
EXEL income_statement (annual, 2025-12-31) — EBITDA: 921756000.00
EXEL income_statement (quarterly, 2025-12-31) — EBITDA: 242856000.00
EXEL cash_flow (annual, 2025-12-31) — End Cash Position: 482488000.00
EXEL cash_flow (quarterly, 2025-12-31) — End Cash Position: 482488000.00
EXEL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -969594000.00
EXEL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -254568000.00
EXEL cash_flow (annual, 2025-12-31) — Free Cash Flow: 844339000.00
EXEL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 326358000.00
EXEL balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3476000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3476000.00
EXEL income_statement (annual, 2025-12-31) — General And Administrative Expense: 518727000.00
EXEL income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 123024000.00
EXEL balance_sheet (annual, 2025-12-31) — Goodwill: 63684000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Goodwill: 63684000.00
EXEL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (annual, 2025-12-31) — Gross PPE: 573493000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 573493000.00
EXEL income_statement (annual, 2025-12-31) — Gross Profit: 2236429000.00
EXEL income_statement (quarterly, 2025-12-31) — Gross Profit: 572182000.00
EXEL income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
EXEL income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
EXEL cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 155296000.00
EXEL income_statement (annual, 2025-12-31) — Interest Income: 69213000.00
EXEL income_statement (quarterly, 2025-12-31) — Interest Income: 17426000.00
EXEL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 69213000.00
EXEL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 17426000.00
EXEL balance_sheet (annual, 2025-12-31) — Inventory: 21686000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Inventory: 21686000.00
EXEL balance_sheet (annual, 2025-12-31) — Invested Capital: 2161319000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2161319000.00
EXEL cash_flow (annual, 2025-12-31) — Investing Cash Flow: 350441000.00
EXEL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 27241000.00
EXEL balance_sheet (annual, 2025-12-31) — Investments And Advances: 603603000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 603603000.00
EXEL balance_sheet (annual, 2025-12-31) — Leases: 111087000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Leases: 111087000.00
EXEL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 173038000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 173038000.00
EXEL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 173038000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 173038000.00
EXEL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 40808000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 40808000.00
EXEL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -947511000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -257618000.00
EXEL income_statement (annual, 2025-12-31) — Net Income: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income: 244528000.00
EXEL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 244528000.00
EXEL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 244528000.00
EXEL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 244528000.00
EXEL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 244528000.00
EXEL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 782570000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 244528000.00
EXEL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 782570000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 244528000.00
EXEL cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -31499000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -6000000.00
EXEL income_statement (annual, 2025-12-31) — Net Interest Income: 69213000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Interest Income: 17426000.00
EXEL cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 390369000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 34398000.00
EXEL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 69213000.00
EXEL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 17426000.00
EXEL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -71220000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -4825000.00
EXEL balance_sheet (annual, 2025-12-31) — Net PPE: 441265000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Net PPE: 441265000.00
EXEL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -8429000.00
EXEL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1157000.00
EXEL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2097635000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2097635000.00
EXEL balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 292582000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 292582000.00
EXEL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 292582000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 292582000.00
EXEL income_statement (annual, 2025-12-31) — Normalized EBITDA: 942266000.00
EXEL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 243550000.00
EXEL income_statement (annual, 2025-12-31) — Normalized Income: 799613810.00
EXEL income_statement (quarterly, 2025-12-31) — Normalized Income: 245199588.81
EXEL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 884267000.00
EXEL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 333515000.00
EXEL income_statement (annual, 2025-12-31) — Operating Income: 892701000.00
EXEL income_statement (quarterly, 2025-12-31) — Operating Income: 235910000.00
EXEL income_statement (annual, 2025-12-31) — Operating Revenue: 3209129000.00
EXEL income_statement (quarterly, 2025-12-31) — Operating Revenue: 813849000.00
EXEL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 262483000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 262483000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Current Assets: 75596000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 75596000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 125382000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 125382000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 3476000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3476000.00
EXEL income_statement (annual, 2025-12-31) — Other Gand A: 446536000.00
EXEL income_statement (quarterly, 2025-12-31) — Other Gand A: 109701000.00
EXEL income_statement (annual, 2025-12-31) — Other Income Expense: -20708000.00
EXEL income_statement (quarterly, 2025-12-31) — Other Income Expense: -648000.00
EXEL cash_flow (annual, 2025-12-31) — Other Non Cash Items: 24619000.00
EXEL cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8671000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 104422000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 104422000.00
EXEL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -198000.00
EXEL income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 46000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Properties: 418595000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Properties: 418595000.00
EXEL balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 576603000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 576603000.00
EXEL balance_sheet (annual, 2025-12-31) — Payables: 29623000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Payables: 29623000.00
EXEL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 118148000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 118148000.00
EXEL balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 102218000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 102218000.00
EXEL balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
EXEL balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
EXEL income_statement (annual, 2025-12-31) — Pretax Income: 941206000.00
EXEL income_statement (quarterly, 2025-12-31) — Pretax Income: 252688000.00
EXEL cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 49137000.00
EXEL cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 7875000.00
EXEL balance_sheet (annual, 2025-12-31) — Properties: 0.00
EXEL balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
EXEL cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -31499000.00
EXEL cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -6000000.00
EXEL cash_flow (annual, 2025-12-31) — Purchase Of Investment: -632497000.00
EXEL cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -154941000.00
EXEL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -8429000.00
EXEL cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1157000.00
EXEL balance_sheet (annual, 2025-12-31) — Receivables: 286916000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Receivables: 286916000.00
EXEL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 83697000.00
EXEL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 26481000.00
EXEL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 29055000.00
EXEL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6946000.00
EXEL cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -947511000.00
EXEL cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -257618000.00
EXEL income_statement (annual, 2025-12-31) — Research And Development: 825001000.00
EXEL income_statement (quarterly, 2025-12-31) — Research And Development: 213248000.00
EXEL income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 20510000.00
EXEL income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 694000.00
EXEL balance_sheet (annual, 2025-12-31) — Retained Earnings: -76830000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -76830000.00
EXEL income_statement (annual, 2025-12-31) — Salaries And Wages: 72191000.00
EXEL income_statement (quarterly, 2025-12-31) — Salaries And Wages: 13323000.00
EXEL cash_flow (annual, 2025-12-31) — Sale Of Investment: 1022866000.00
EXEL cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 189339000.00
EXEL income_statement (annual, 2025-12-31) — Selling General And Administration: 518727000.00
EXEL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 123024000.00
EXEL balance_sheet (annual, 2025-12-31) — Share Issued: 262483000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Share Issued: 262483000.00
EXEL income_statement (annual, 2025-12-31) — Special Income Charges: -20510000.00
EXEL income_statement (quarterly, 2025-12-31) — Special Income Charges: -694000.00
EXEL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 112983000.00
EXEL cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 20097000.00
EXEL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2161319000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2161319000.00
EXEL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2097635000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2097635000.00
EXEL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3466190.00
EXEL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -22411.19
EXEL income_statement (annual, 2025-12-31) — Tax Provision: 158636000.00
EXEL income_statement (quarterly, 2025-12-31) — Tax Provision: 8160000.00
EXEL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
EXEL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.03
EXEL balance_sheet (annual, 2025-12-31) — Total Assets: 2844423000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Assets: 2844423000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Capitalization: 2161319000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2161319000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Debt: 173038000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Debt: 173038000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2161319000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2161319000.00
EXEL income_statement (annual, 2025-12-31) — Total Expenses: 1427425000.00
EXEL income_statement (quarterly, 2025-12-31) — Total Expenses: 362753000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 683104000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 683104000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1401134000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1401134000.00
EXEL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 277460000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 277460000.00
EXEL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 872191000.00
EXEL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 235216000.00
EXEL income_statement (annual, 2025-12-31) — Total Unusual Items: -20510000.00
EXEL income_statement (quarterly, 2025-12-31) — Total Unusual Items: -694000.00
EXEL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -20510000.00
EXEL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -694000.00
EXEL balance_sheet (annual, 2025-12-31) — Working Capital: 1037645000.00
EXEL balance_sheet (quarterly, 2025-12-31) — Working Capital: 1037645000.00
EXEL income_statement (quarterly, 2026-03-31) — +Operating Expense: 339518000.00
EXEL income_statement (quarterly, 2026-03-31) — +Total Revenue: 610812000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 24154000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 328947000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2151703000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 649144000.00
EXEL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 258329000.00
EXEL income_statement (quarterly, 2026-03-31) — Basic EPS: 0.81
EXEL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 482488000.00
EXEL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2034000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 169541000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 254000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 226152000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 777207000.00
EXEL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -457111000.00
EXEL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -51070000.00
EXEL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 251845000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -17897000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 4044000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Inventory: -3389000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Payable: -17897000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -13853000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 58653000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Receivables: -42031000.00
EXEL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -620000.00
EXEL cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -42031000.00
EXEL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -256336000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Common Stock: 254000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1935748000.00
EXEL cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -430352000.00
EXEL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 19953000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 93131000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Current Assets: 1208637000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 370975000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Current Provisions: 65892000.00
EXEL cash_flow (quarterly, 2026-03-31) — Depreciation: 6948000.00
EXEL cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6948000.00
EXEL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6948000.00
EXEL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 267322000.00
EXEL income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.79
EXEL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — EBIT: 251341000.00
EXEL income_statement (quarterly, 2026-03-31) — EBITDA: 258289000.00
EXEL cash_flow (quarterly, 2026-03-31) — End Cash Position: 226152000.00
EXEL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -457111000.00
EXEL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 249811000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -415000.00
EXEL income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 139602000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Goodwill: 63684000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 378398000.00
EXEL income_statement (quarterly, 2026-03-31) — Gross Profit: 590859000.00
EXEL income_statement (quarterly, 2026-03-31) — Interest Income: 16127000.00
EXEL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 16127000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Inventory: 26605000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1935748000.00
EXEL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -51070000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 649144000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 649144000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 169541000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 169541000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -430352000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 210467000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 210467000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 210467000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -525000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Interest Income: 16127000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -49036000.00
EXEL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 16127000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -34231000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Net PPE: 378398000.00
EXEL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1509000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1872064000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 293730000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 293730000.00
EXEL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 258289000.00
EXEL income_statement (quarterly, 2026-03-31) — Normalized Income: 210467000.00
EXEL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 251845000.00
EXEL income_statement (quarterly, 2026-03-31) — Operating Income: 251341000.00
EXEL income_statement (quarterly, 2026-03-31) — Operating Revenue: 851189000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 253701000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 75878000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 100286000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -415000.00
EXEL income_statement (quarterly, 2026-03-31) — Other Gand A: 122870000.00
EXEL income_statement (quarterly, 2026-03-31) — Other Income Expense: 219000.00
EXEL cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6000000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 117329000.00
EXEL income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 219000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Properties: 378398000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 551055000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Payables: 24154000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 117285000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 87512000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
EXEL income_statement (quarterly, 2026-03-31) — Pretax Income: 267687000.00
EXEL cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 7472000.00
EXEL cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -525000.00
EXEL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -274161000.00
EXEL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1509000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Receivables: 328947000.00
EXEL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 19953000.00
EXEL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6948000.00
EXEL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -430352000.00
EXEL income_statement (quarterly, 2026-03-31) — Research And Development: 199916000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -215794000.00
EXEL income_statement (quarterly, 2026-03-31) — Salaries And Wages: 16732000.00
EXEL cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 225125000.00
EXEL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 139602000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Share Issued: 253701000.00
EXEL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 29050000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1935748000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1872064000.00
EXEL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
EXEL income_statement (quarterly, 2026-03-31) — Tax Provision: 57220000.00
EXEL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
EXEL balance_sheet (quarterly, 2026-03-31) — Total Assets: 2593593000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1935748000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Debt: 169541000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1935748000.00
EXEL income_statement (quarterly, 2026-03-31) — Total Expenses: 359471000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 657845000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1384956000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 286870000.00
EXEL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 251341000.00
EXEL balance_sheet (quarterly, 2026-03-31) — Working Capital: 837662000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -1391000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 41000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 10018000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Cash Equivalents: 13000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Cash Financial: 15914000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Common Stock Issuance: 42736000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Construction In Progress: 9733000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Current Debt: 2728000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Current Provisions: 2355000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Financial Assets: 0.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Finished Goods: 10551000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 36973000.00
EXENS.PA income_statement (annual, 2021-12-31) — Interest Expense: 37599000.00
EXENS.PA income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 37599000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: -8438000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 42736000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Issuance Of Debt: 212511000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Land And Improvements: 1802000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Long Term Debt: 199299000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 212065000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -258902000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Long Term Provisions: 7962000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
EXENS.PA income_statement (annual, 2021-12-31) — Minority Interests: 0.00
EXENS.PA cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 42736000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Net Debt: 186100000.00
EXENS.PA income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
EXENS.PA cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -58789000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -46837000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -19587000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -11952000.00
EXENS.PA cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 241000.00
EXENS.PA balance_sheet (annual, 2021-12-31) — Other Payable: 223000.00